Amneal Pharmaceuticals, Inc. 4

EVP & Chief Legal Officer Jason B. Daly sold a total of 216,613 shares of Amneal Pharmaceuticals, Inc. Class A Common Stock for roughly $3.77 million over two days.

On August 11 and 12, 2026, Jason B. Daly, EVP and Chief Legal Officer of Amneal Pharmaceuticals, Inc., reported open-market sales of Amneal Class A Common Stock totaling 216,613 shares at weighted average prices of $17.70 and $17.40 per share, respectively. The 6,613-share sale on August 11 generated proceeds of approximately $117,050, while the 210,000-share sale on August 12 generated proceeds of approximately $3,654,000, for aggregate sale proceeds of about $3.77 million. These transactions, executed in multiple trades within stated price ranges, reduced Daly’s direct holdings from 271,784 shares before the first sale to 245,171 shares after the August 11 transaction and then to 35,171 shares after the larger August 12 disposition.

Filing Facts

CIK

1723128

Ticker

AMRX

Form

4

Source Type

fda

Accession

0001628280-26-056754

Alert Tier

7